Condition
Paraneoplastic Syndromes, Ocular
Ophthalmology
Overview
Ocular manifestations secondary to various NEOPLASMS in which antibodies to antigens of the primary tumor cross-react with ocular antigens. This autoimmune response often leads to visual loss and other ocular dysfunctions.
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Paraneoplastic Syndromes, Ocular
- Topic type
- Condition
- Category
- Ophthalmology
- MeSH classification
- C04.588.364.738|C04.730.900|C11.319.466
Preparing for an appointment about Paraneoplastic Syndromes, Ocular
If you are speaking with a healthcare professional about Paraneoplastic Syndromes, Ocular, it can help to prepare a few details in advance.
- Write down your symptoms and when they started.
- Bring details of any medicines, supplements or previous treatments.
- Ask what tests or assessments may be needed.
- Ask what treatment or management options may be suitable.
- Ask when you should seek urgent medical help or follow-up care.
Finding care related to Paraneoplastic Syndromes, Ocular
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Paraneoplastic Syndromes, Ocular
No clinics are currently linked directly to Paraneoplastic Syndromes, Ocular on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.